Amgen’s cholesterol drug Repatha proved effective at lowering the risk of heart attacks, strokes and death in patients with heart disease in a recent clinical trial, reports Reuters. When reporting ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: An Amgen sign is seen at the company's headquarters in Thousand Oaks, California, U.S., November 6, 2019.
Amgen slashed the price of its cholesterol medication by more than half for U.S. patients through a new medication-access program amid the Trump administration's call to lower drug prices. The ...
(CNN) — The pharmaceutical company Amgen announced Wednesday that it will decrease the price of its cholesterol lowering drug Repatha by 60%. The company said some patients weren't filling their ...
Econostrum on MSN
TrumpRx launches: Are prescription drug prices really about to drop?
President Donald Trump is officially unveiling a new initiative aimed at reducing prescription drug costs for Americans. The ...
THOUSAND OAKS, Calif., Aug. 25, 2025 /PRNewswire/ -- Amgen (AMGN) today announced that the U.S. Food and Drug Administration (FDA) has broadened the approved use of Repatha ® (evolocumab) to include ...
Amgen AMGN announced the launch of a new direct-to-consumer (DTC) program called AmgenNow, which will offer significant discounts on its marketed drugs. The company has initiated this DTC program with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results